SkyAI, Inc. SKYA
Technology, Inc. is a medical device sales and distribution enterprise focused on the marketing and distribution of syringe products
and related drug-delivery systems. We previously designed and manufactured a portfolio of conventional and safety syringes for clinical,
pharmaceutical, and specialty applications and continues to market certain remaining inventory to hospitals, clinics, healthcare providers,
and medical supply organizations in both domestic and international markets. We plan to expand its distribution platform by representing
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $204.1K | — | — | — | — | — |
| Cost of revenue | $617.4K | — | — | — | — | — |
| Gross profit | -$413.3K | — | — | — | — | — |
| R&D | $198.8K | $531.2K | $1.6M | $2.3M | $1.7M | — |
| SG&A | $16.1M | $5.0M | $8.5M | $6.5M | $2.8M | — |
| Total operating expenses | $276.1M | $5.6M | $10.1M | $8.7M | $4.5M | — |
| Operating income | -$269.7M | -$5.6M | -$10.1M | -$8.7M | -$4.5M | — |
| Interest expense | $416.7K | $1.7M | $138.1K | $1.3M | $166.7K | — |
| Pre-tax income | -$270.3M | -$5.2M | -$9.9M | -$4.6M | — | — |
| Income tax | — | $30.0K | $30.0K | — | — | — |
| Net income | -$282.5M | -$9.3M | -$9.8M | -$4.6M | -$4.7M | — |
| EPS, basic | -11.16 | -2,219.92 | -16.61 | -0.57 | -0.96 | — |
| EPS, diluted | -11.16 | -2,219.92 | -16.61 | -0.57 | — | — |
| Shares, diluted (wtd. avg.) | 25.3M | 4,188 | 592,396 | 8.1M | 4.9M | — |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $10.4M | $754.8K | $3.0M | $4.2M | $1.5M | — |
| Inventory | $645.3K | $538.8K | $1.7M | $185.8K | $122.0K | — |
| Total current assets | $18.9M | $3.2M | $4.8M | $4.4M | $1.6M | — |
| Property, plant and equipment | $81.2K | $1.2M | $6.8M | $7.0M | $3.8M | — |
| Other intangibles | — | $32.5K | $52.5K | $62.5K | — | — |
| Total assets | $269.1M | $7.3M | $11.8M | $11.8M | $5.9M | — |
| Accounts payable | $590.7K | $693.2K | $794.1K | $543.2K | $804.1K | — |
| Short-term debt | $3.1M | — | — | — | — | — |
| Total current liabilities | $4.7M | $5.2M | $3.7M | $2.0M | $2.8M | — |
| Total liabilities | $4.7M | $5.3M | $3.9M | $2.2M | $2.8M | — |
| Retained earnings | -$316.9M | -$34.4M | -$25.1M | -$15.3M | -$10.7M | — |
| Total equity | $264.4M | $2.0M | $7.9M | $9.6M | $3.1M | $2.1M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$11.0M | -$4.4M | -$8.5M | -$6.4M | -$3.1M | — |
| Depreciation and amortisation | $132.5K | $472.6K | $876.1K | $647.7K | $28.7K | — |
| Stock-based compensation | — | $520.8K | $963.0K | $1.0M | $1.2M | — |
| Capital expenditure | — | $138.8K | $698.3K | $542.7K | $2.2M | — |
| Investing cash flow | -$187.5M | -$1.0M | -$698.3K | -$3.1M | -$2.3M | — |
| Financing cash flow | $215.5M | $5.9M | $8.0M | $12.2M | $5.2M | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001493152-26-014261.
Plot the figures US dollars
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | $204.1K |
| Gross profit | — | — | — | — | — | -$413.3K |
| Net income | — | -$4.7M | -$4.6M | -$9.8M | -$9.3M | -$282.5M |
Recent filings and events
- Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
- Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03
- Other event Item 8.01
- Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
- Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
- Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
- Material agreement signed Item 1.01
- Officer or director change Item 5.02
- Material agreement signed Item 1.01
- Charter or fiscal year changed Item 5.03
- Code of ethics change The code of ethics changed, or somebody was excused from part of it. Item 5.05
- Other event Item 8.01
Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.
Others in SIC 6199
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| AXP | AMERICAN EXPRESS CO | $211.52B | 20.4x | 6.4% |
| MSTR | Strategy Inc | $51.47B | — | 3.0% |
| COIN | Coinbase Global, Inc. | $43.32B | 37.0x | 9.4% |
| SYF | Synchrony Financial | $23.96B | 7.9x | — |
| CRCL | Circle Internet Group, Inc. | $21.32B | — | 624.0% |
| SOFI | SoFi Technologies, Inc. | $18.88B | 37.5x | 23.1% |
| BMNR | BITMINE IMMERSION TECHNOLOGIES, INC. | $13.51B | 1.7x | 84.1% |
| CHYM | Chime Financial, Inc. | $11.23B | — | 30.7% |